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1. LITERATURE REVIEW AND RESEARCH OBJECTIVES  
In my thesis I analyze and describe the nature and functioning of the professional networks 
developed among general practitioners and specialist as a result of ties established between 
doctors and patient while provisioning medical services. My research focuses on the impact of 
the strength of ties between general practitioners and specialists developed in the practice of 
shared care on the health status of the patient and the costs of medication.   
The significance of the present thesis may lie in investigating the way general practitioner-
specialist professional networks actually operate and its economic policy implications. By 
understanding these networks, healthcare economists and politicians might be able to 
strengthen those relationships which enhance the probability of providing for lower pharmacy 
costs at comparable or improved health care quality standards. Therefore, understanding these 
relationships ought to be seen as serving important social objectives. 
The strength of this research lies in the data utilized.  I defined the strength of ties between 
doctors in accordance with the number of patients receiving care by the same two doctors. 
These professional ties were analyzed on the basis of prescription data recorded. Due to the 
unique data, all ties between physicians included in the database can be mapped with great 
accuracy.   
In my empirical research I first address the question whether general practitioners and 
specialists maintaining close professional ties with each other - at comparable patient health 
levels as a minimum - are successful in reducing pharmacy costs.  Should it be concluded that 
the pharmacy costs - at least when assuming comparable levels of patient health status – are 
significantly lower in strong general practitioner-specialist ties; then obviously the creation 
and maintenance of such ties serve the best interests of all parties concerned.  In accordance 
with the foregoing deliberations, it appears that the simultaneous exploration of two 
hypotheses is required as presented below: 
H1: The health status of patients treated in strong general practitioner-specialist 
relationships tends to be better.  
H2: The pharmacy costs carried by patients treated in strong general practitioner-
specialist relationships tend to be lower.  
The novelty of my research is not only evidenced by the fact that no similar studies have been 
pursued and published in reliance on quantitative methods but also that no attempt has been 
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made so far in the professional literature of the field to provide a simultaneous and 
interdependent presentation of the above two hypotheses.  
As regards to the first hypothesis, certain research projects have been conducted on the field 
in the United States of America. In particular, Barnett et al [2012] and Pollack et al [2013] 
concluded that in an environment where one doctor provides treatment for a patient with the 
collaborative care of a small number of other doctors, such collaboration will result in an 
improved patient health status - probably on account of a more efficient exchange of 
professional information and the better management of the health care process.  These 
findings are supported by the systematic literature reviews of Lemieux et al [2006] and Bosch 
et al [2009] where the authors conclude that close ties among doctors providing shared care 
result in enhanced clinical performance and a better health status for the patient.  In summary, 
it can be stated that similar research projects have only been conducted outside Europe and 
even those have fell short of addressing the health care systems of other countries. The 
research performed by Pollack et al [2013] stand closest to my thesis. It is important to note, 
that the results of research carried out outside Europe are not applicable or transferable to 
Hungary due to substantial differences between the health care systems. Nonetheless, the 
methodology employed in previous research projects may well provide a useful background 
for this research. 
The second hypothesis relies on the assumption that in cases where doctors share the 
treatment of a large number of patients, pharmacy costs will be reduced.  Examining the 
treatment of diabetes Walraven et al [2010] have pointed out in their systematic literature 
review that improved coordination of medical care results in a decrease in the usage of health 
care services; especially in the area of inpatient care and emergency care.  Barnett et al [2012] 
and Pollack et al [2013] have shown that the cost of care provisioning for those patients 
whose doctors work with a number of other patients in a shared care environment are lower 
when compared to other settings, probably due to more efficient collaboration among the 
physicians involved.  The reduction of pharmacy costs is an important objective considering 
the fact that within the expenditures laid out for medical services - in treating diabetes as an 
example - the share of pharmacy costs exceeds more than 20% of the total costs (Pollack et al 
[2013]).  
Should we find that the health status of patients treated in strong general practitioner-
specialist relationships is better or at least equal to those treated in weak general practitioner-
specialist relationship then it is important to understand the reasons of such improved 
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performance. Such understanding may help developing strategic recommendations for 
healthcare strategists seeking to create and strengthen efficient ties between general 
practitioners and specialists.   
In order to understand better the relationship among doctors participating in shared care 
arrangements, it is important to investigate whether such relationships are dominantly created 
between general practitioners and specialists of similar professional characteristics.  The 
findings of the previous research are contradictory. Landon et al [2012] concludes that the 
homophyly is present in these relationships; physicians tend to share patients with other 
physicians with similar physician-level and patient-panel characteristics. On the other hand, 
Barnett et al [2012] concludes that the homophyly cannot be observed in their sample. 
H3: Doctors having strong ties to one another share many similarities (homophyly). 
Due to the contradictory previous findings I will investigate the collaborations among doctors 
based on the two definitions (the characteristics of doctors with concentrated vs. dispersed 
referral structures; and the characteristics of doctors being preferred versus non-preferred, the 
detailed definitions can be found in section 2.1). I expect to find substantial differences in the 
nature and quality of the various sets of relationships between general practitioners, on the 
one hand, and specialists on the other. Such recognized differences would enable drawing 
policy recommendations aiming at an enhanced level of collaboration between general 
practitioners and specialists assuming that enhanced collaboration results in lower pharmacy 
costs.  Following this argumentation, the following hypotheses have to be tested: 
H4a: Based on their characteristics, general practitioners maintaining a concentrated 
referral structure can be differentiated from those maintaining a dispersed referral 
structure. 
H4b: Based on their characteristics, preferred specialists can be differentiated from 
those defined as non-preferred. 
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2. METHODOLOGY 
2.1. Collaborations 
The research process is summarised in Figure 1.  
Figure 1. Research design
 
The number of specialists collaborating with particular general practitioners varies widely. In 
addition, the number of patients treated jointly in any particular relationship also varies 
significantly. For these reasons, the definition of the different types of collaboration is not 
straightforward. In relationships where shared care is provided for a higher number of patients 
the ties are presumably stronger since it can be assumed that professional interaction takes 
place more frequently among the doctors.  The distribution of the strength of general 
practitioner-specialist relationships is skewed and their relationship is not linear as inferred by 
Pollack et al [2013]. On the basis of previous research and due to the differences in the 
number of patients treated jointly by collaborating doctors, we need a relative threshold rather 
than an absolute one, such as the number of patients would be, for the definition of the 
strength of ties. The two decisive factors in defining the threshold values are the number of 
patients receiving shared care and the distribution of patients among specialists.  
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In my research I employed three different definitions for collaboration (Fig 1.).   
The definition of strong and weak ties 
In my dissertation, I first allocated patients to general practitioner-specialist relationships. If a 
patient consulted several specialists during the observation period, then I allocated the patient 
to a number of general practitioner-specialist relationships simultaneously, in the following 
manner.  I first defined the ratio of pharmaceuticals prescribed for one patient as suggested by 
one particular specialist over all pharmaceuticals prescribed for that patient as suggested by 
specialists. This ratio was then allocated as a weight to the patient of the relevant specialist.  
Next, I arranged the 6323 general practitioner-specialist relationships according to patient 
ratios in diminishing order. I qualified the relationship as strong in cases which fall into the 
uppermost quintile of collaborative ties. This criterion was met, for the purposes of my 
research, in cases where one general practitioner referred more than 19.2% of his/her patients 
to one particular specialist.   In contrast, a particular general practitioner-specialist 
relationship was qualified as weak if that relationship fell into the lowest quintile of the cases 
studied.  In this category, a particular general practitioner provides shared care for less than 
2.3% of his/her patients in collaboration with one particular specialist (Fig 2.). 
Figure 2. Strong and weak ties in the example of three general practitioners 
 
Data source: DoktorInfo database. 
The definition of general practitioners having concentrated vs. dispersed referral structures 
Following the definition of strong vs. weak ties, for a more thorough analysis it is necessary 
to provide a definition of concentrated vs. dispersed referral structures characterizing general 
practitioners.    
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For determining the concentration of referral structures, I used the most widely accepted 
measure, the Herfindahl-Hirschman index as applied to individual general practitioners 
(Rhoades [1993]), 
𝐻𝐻𝐼 = ∑ 𝑠𝑖
2𝑛
𝑖=1 , where 
𝑠𝑖 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑟𝑒𝑓𝑒𝑟𝑟𝑒𝑑 𝑡𝑜 𝑜𝑛𝑒 𝑆𝑃 𝑏𝑦 𝑜𝑛𝑒 𝑝𝑎𝑟𝑡𝑖𝑐𝑢𝑙𝑎𝑟 𝐺𝑃
𝑎𝑙𝑙 𝑝𝑎𝑡𝑖𝑒𝑛𝑡 𝑜𝑓 𝑜𝑛𝑒 𝑝𝑎𝑟𝑡𝑖𝑐𝑢𝑙𝑎𝑟 𝐺𝑃
 
 
I defined the HHI index for each general practitioner and, subsequently, I sorted the 794 
general practitioners in a sequential order. Based on this sequence, I placed general 
practitioners into categories as characterized by concentrated vs. dispersed referral structures.  
This means that I applied a relative indicator: I defined the referral structure of a particular 
general practitioner as concentrated when his/her practice fell into the uppermost quintile of 
the cases studied.  Both the uppermost and the lowest quintiles contained 158 practices.   
The definition of preferred vs. non-preferred specialists  
By definition, a specialist maintains strong ties with a general practitioner if he/she is one of 
the preferred specialist of that particular general practitioner. A specialist qualifies as being a 
preferred partner of a general practitioner if the latter refers at least 30% of his/her patients, or 
a minimum of nine patients, to that particular specialist.  One general practitioner may have 
more than one preferred specialist.  Preferred specialists receive patients with referrals from 
five general practitioners or more.   
2.2. Databases  
In my dissertation, I have relied on two main and three additional databases. Prescription data 
have been provided for research purposes by the DoktorInfo Ltd. Nearly 900 general 
practitioners insert prescription data into the Doktorinfo databases on a daily basis. The 
another main sources of data used in this research is the Health Centre of Registry and 
Training database (hereinafter referred to as HCRT database). By relying on the HCRT 
database, I have downloaded socio-demographic and workplace-related characteristics for 
general practitioners and specialists (HCRT [2015]). I have used three additional databases in 
my research. The Price Subsidy Department of the National Health Insurance Fund of 
Hungary (NHIFH) regularly issues a Public Pharmacy Register (PUHA), which is a public 
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database on subsidized pharmaceuticals (NHIFH [2014]). Moreover, I used a database 
containing 2011 pharmacy prices to define the full prices of pharmaceutical products. Finally, 
the 2011 Annal of the Designation Register of Populated Areas published by the Hungarian 
Central Statistical Office (HCSO) contains in its database the population figures of all 
inhabited settlements which enabled me to categorize all towns examined in this research by 
their size (HCSO) [2011]). Using Google Maps, I was able to calculate public road distances 
between health care practices.  
2.3. Patient population 
The selection of patients with type 2 diabetes offers a promising approach to the investigation 
of collaborative practices between general practitioners and specialists for three reasons. First, 
patients suffering from this chronic disease constitute the largest patient population receiving 
shared care provided jointly by general practitioners and specialists.  Secondly, this area of 
health services produces the largest number of general practitioner prescriptions issued on the 
recommendation of specialists. Thirdly, medication applied in the treatment of diabetes can 
only be prescribed by a well-defined group of licensed specialists comprising internists and 
endocrinologists. (Ministerial Decree 44/2004. - IV. 28. - ESzCsM - Ministry of Health, 
Social and Family Care). As a result, I was able to delineate and analyze the largest possible 
subset in terms of the number of prescriptions written.  
2.4. Output variables 
In this section, I discuss the definitions of the health status of patients, on the one hand, and 
pharmacy costs, on the other.  These variables are referred to as output variables. In my 
dissertation, I use approximate indices on the health status of patients based on diagnosed and 
treated comorbidities. 
In my research, I employed four different comorbidity indices:   
• Charlson comorbidity index (Charlson et al [1987]):  
The Charlson comorbidity index offers predictions as to the 10 year survival 
probability of the patient using a weighted scoring system which evaluates the 
presence or the absence of 19 different diseases. (Charlson et al [1987]).  
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• Quan-modified Charlson comorbidity index (Quan et al [2011]):  
Considering the fact that since the first publication of the Charlson comorbidity index 
in 1984 several medical innovations affected the mortality rates related to particular 
diseases it could be argued that the application of this rating system may require 
adjustments. Therefore, I also define the relevant index values on the basis of the 
Quan-modified Charlson comorbidity rating method: I revise the mortality rate scores 
assigned to particular diseases while the list of diseases remains unchanged (Quan et al 
[2011]). 
• Elixhauser measure (Elixhauser et al [1998]):  
The Elixhauser measure examines the occurrence of 30 carefully selected diseases 
expressing their aggregate frequency of occurrence.  
• ATC-based comorbidity count:  
The fourth comorbidity rating technique applied in my research is an alternative index 
referred as the number of prescription drugs dispensed in the relevant literature (e.g., 
Lix et al [2016]). This alternative index relies on the ATC codes entered on the 
prescriptions. My objective in using this alternative index was the rectification of 
potential mistakes occurring in the ICD codes. With the help of the comorbidity 
indices based on the ATC codes, I took account of the occurrences of diseases with 
respect to which the patient received at least one prescription in each quarter year 
analyzed.  
In defining pharmacy costs, I calculated the aggregate cost of medication, without subsidies, 
prescribed by the general practitioner for every single patient throughout the years 2010 and 
2011 using information retrieved from the NHIFH database. It is important to stress that, in 
the course of this research, I was not using medication expenditures carried by the patient 
when calculating pharmacy cost. Instead, I used the full prices which would be payable for 
the pharmaceuticals in the pharmacy shops by the patient complemented by government 
subsidies. As a result, I was able to take into account the pharmacy cost for the whole society.  
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3.  RESULTS 
3.1. Characteristics of the collaboration structure 
In my empirical research, I explore the characteristics of relationships between general 
practitioners and specialist which emerge in the process of providing care jointly for patients 
with type 2 diabetes (Fig. 3.). 
Figure 3. The network structure of general practitioners and specialists 
 
Data source: DoktorInfo database. 
In the sample, both the number and the distribution of patients treated by particular general 
practitioners show large variation.  On average, a general practitioner collaborates with eight 
specialists - nonetheless, the standard deviation of this factor in the sample is fairly high.  The 
structure of collaboration between doctors is rather fragmented. The number of patients 
receiving shared care in any particular general practitioner-specialist relationship may 
substantially differ from case to case. Also, the number of specialists collaborating with one 
particular general practitioner may show large variations. Therefore, in the analysis of 
relationships I used a relative threshold. 
 
11 
 
3.2. Health status of patients and pharmacy costs  
In this subsection, I take a close look at the health status of patients and the pharmacy costs of 
patients treated in strong general practitioner-specialist relationships as opposed to those 
receiving care in weak relationships.   
Table 1 shows the test results calculated for the first two hypotheses.  All four comorbidity 
indices support the conclusion that patient health status is not influenced by the nature of 
general practitioner-specialist relationships, be the respective ties classified as either strong or 
weak.  The health status of patient, regardless of the comorbidity indices used, are very much 
the same and do not appear to be influenced by the strength of specialist-general practitioners 
relationships. This implies that I have to reject my first hypothesis.   
Table 1. Description of strong and weak general practitioner-specialist relationships in 
the function of various outcome measures 
Outcome measures 
Strong ties 
(uppermost 
quintile, mean 
value) 
Weak ties 
(lowest 
quintile, 
mean value) 
p-
value  
Patient health status (excluding diabetes) 
Charlson comorbidity index 0.93 0.91 43.64 
Quan-modified Charlson comorbidity 
index 
0.60 0.60 82.66 
Elixhauser measure (based on ICD-10 
codes) 
1.98 1.95 42.33 
ATC-based comorbidity count (based 
on third-level ATC codes) 
8.01 7.98 83.93 
Pharmacy costs (based on retail 
prices as of January 2010; thousand 
HUF - Hungarian Forint) 
612.18 721.41 0.00 
Data source: DoktorInfo and the NHIFH databases. 
On the other hand, as shown in Table 1, the strength of ties between doctors certainly 
influences the size of the pharmacy costs. Patients treated in strong general practitioner-
specialist relationships carry pharmacy costs which are 15.14% smaller than those carried by 
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patients treated in weak relationships. The difference is significant, thus, my second 
hypothesis has to be accepted.   
For a better understanding of the differences in pharmacy costs, in addition to the by-variate 
analyses I have also performed a multivariate regression analyses.   This multivariate 
regression analyses might help explaining the observed differences in pharmacy costs.  I 
found that the strength of ties, similarly to many patient characteristics (gender, age, severity 
of diabetes condition) bear a significant impact on pharmacy costs, alongside with the type of 
therapy applied (insulin based vs non-insulin based) (Table 2). 
Table 2.  Multivariate regression applied to the pharmacy costs carried by patients 
Independent variables 
Standardized 
Coefficients Sig. 
Beta 
Strong and weak ties between general practitioners and 
specialists (0 - for weak; 1 - for strong)  
0.011 0.030 
Quan-modified Charlson comorbidity index -0.009 0.113 
Patient's gender (0-female, 1-male) -0.024 0.000 
Diabetes severity (0- without complication, 1-with 
complications) 
0.014 0.007 
Type of therapy (0-no insulin, 1-insulin based)  0.202 0.000 
The number of prescriptions per patient (units) 0.570 0.000 
The number of consultations per patient  
(with the specialist, generating new recommendations for 
prescription medicines)   
0.062 0.000 
Patients' age  0.174 0.001 
Patients' age squared  -0.272 0.000 
Data source: DoktorInfo and the NHIFH databases. 
In summary, it can be argued that the strength of ties exerts no impact on the health status of 
patients.  This result is in line with previous research (O'Connor et al [2008], Craven and 
Bland [2006], Smith et al [2007]). 
The finding that the pharmacy costs of patients treated in strong general practitioners-
specialist relationships are significantly higher than the pharmacy cost of patients treated in 
weak general practitioners-specialist relationships, is in line with previous research. In 
particular, Barnett et al [2012], Landon et al [2012] and Pollack et al [2013] have also found 
that those relationships which provide shared care for a larger number of patients generate 
comparatively lower pharmacy costs.   
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3.3. Characteristics of strong vs. weak ties 
Having evaluated hypotheses H1 and H2, the question arises: if the reduction of health care 
costs at the level of the whole society is found to be attributable to strong general practitioner-
specialist ties, as demonstrated, then can we identify those characteristics of collaborating 
doctors which might support the development of such relationships?   
My empirical research did not find support for the third hypothesis (H3) related to the 
emergence of homophyly in strong general practitioner-specialist relationships. It has been 
demonstrated that in strong relationships doctors have a long record in collaborating with 
their partners in shared care, and that their practices are geographically close to each other.  
The impact of homophyly is limited, and it can only be detected in the number of specialites 
acquired. General practitioners tend to refer their patients to specialists they know well and 
with whom they have a long standing collaborative partnership.  This result is consistent with 
the findings of Barnett et al. [2012], who also argued that homophyly cannot be detected in all 
categories of doctor characteristics.   
Subsequently, I investigated the possible differences in the characteristics of general 
practitioners maintaining a concentrated referral structure as opposed to those working with a 
dispersed referral structure (H4a), and whether preferred specialists differ in their 
characteristics from their non-preferred colleagues (H4b).   
My results show that general practitioners maintaining concentrated referral structures mostly 
work in minor municipalities, and that graduation from the same medical school probably 
impacts the development of strong ties. It may well be that general practitioners working in 
minor municipalities are constrained in their choice of selecting a specialist. In comparing 
preferred as opposed to non-preferred specialists, I came to the conclusion that preferred 
specialists are usually older, have more professional experience, the period spent in their 
current practices is usually longer, they work mostly in small municipalities, fill senior 
management positions in their respective medical institutions and have a relatively small 
number of colleagues of the same specialisation working in the neighbourhood.  Accordingly, 
it can be concluded that professional experience is an important consideration in the choice of 
a specialist made by either the general practitioner or the patient, similarly to the professional 
recognition and acclaim accorded to the specialist also assuming that professional reputation 
is probably a consequence of  more experience. 
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The above findings are in line with my intuitions regarding the fact that the longer the period 
of joint collaboration the more intimate is the mutual understanding of the parties, the more 
extensive the familiarity with each other's therapeutic techniques and preferences, the greater 
the confidence of recommending each other as trusted professionals, and the more smooth is 
the communication developed with each other. The distance between the practices is highly 
important for the patient since, obviously, the majority of patients is either not willing, or is 
not capable of travelling large distances. The third major factor contributing to the emergence 
of strong ties between collaborating doctors is related to the obligation to provide healthcare 
services within particular geographic areas.   
In weak relationships the ratio of distances of above 50 km between practices is fairly large 
(28.2%). Given the freedom of choosing physicians, in case of larger distances instead of the 
regionally assigned specialist, the patient is more likely to select a specialist of his/her own 
choice with whom he/she is already well acquainted; or one recommended by somebody else.  
In these cases it can be reasonably assumed that the general practitioner does not know the 
specialist personally, and therefore joint treatment is only a theoretical. 
3.4. An analysis for the small and medium-sized municipalities  
The obligation to provide healthcare services within particular geographic areas ought to be 
viewed as a critical factor in developing strong vs. weak ties: It may well be that the 
obligation to provide healthcare services within particular geographic areas predetermines the 
strength of ties in small communities. Therefore, I have investigated weather the health status 
and pharmacy costs of patients receiving care in strong general practitioner-specialist 
relationships is significantly different from the health status and pharmacy costs of patients 
receiving care in weak general practitioner-specialist relationships in small and medium-sized 
municipalities as well.  In this analysis moderating coefficients were added to the model.  
Having only small and medium-size municipalities in the sample, the results show that in 
geographic areas where the number of available specialists is low the chances for developing 
strong collaborative relationships are higher as compared to the whole sample (Table 3).  Of 
the 794 general practitioners in the sample, 158 have concentrated referral structures and only 
six of the latter maintain practices in Budapest. In the case of general practitioners with 
dispersed referral structures these ratios show an inverse relationship.   
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Table 3. Description of strong and weak general practitioner-specialist relationships in 
the function of various outcome measures in small and medium-sized municipalities 
Outcome measures 
Strong ties 
(uppermost 
quintile, mean 
value) 
Weak ties 
(lowest 
quintile, 
mean value) 
p-
value  
Patient health status (excluding diabetes) 
Charlson comorbidity index 0.88 0.91 16.03 
Quan-modified Charlson comorbidity 
index 
0.59 0.60 58.15 
Elixhauser measure (based on ICD-10 
codes) 
1.93 1.96 30.81 
ATC-based comorbidity count (based 
on third-level ATC codes) 
7.98 8.38 0.00 
Pharmacy costs (based on retail 
prices as of January 2010; thousand 
HUF - Hungarian Forint) 
591.89 696.60 0.00 
Data source: DoktorInfo, HCSO and HCRT databases. 
Patients treated by general practitioners working in small and medium-size municipalities and 
maintaining concentrated referral structures display no significant differences in terms of 
health status, while the pharmacy costs carried by the same patients are significantly lower.  
We might thus conclude that even in geographic areas where the number of available 
specialists is limited the finding remains valid: doctors working in strong collaborative ties 
contribute in a meaningful way to the reduction of pharmaceutical expenditures carried by 
society.  The obligation to provide healthcare services within particular geographic areas is 
thus not the only factor responsible for the emergence of strong ties.  
3.5. Policy recommendations 
The most important policy implication of my dissertation pertaining to healthcare economics 
is related to the free choice of healthcare providers. Free choice of providers has been recently 
enacted in a number of developed countries, including the Netherlands and the United 
Kingdom. In an environment where patients can freely choose their specialists, the free choice 
may compel the general practitioners to expand the circle of collaborating specialist in the 
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provisioning of shared care.  In my dissertation I have shown that the patients of those general 
practitioners who provide care in collaboration with a relatively larger number of specialists 
carry higher pharmacy costs.  This might be achieved through offering patients limited rather 
than unrestricted choice-patients need excellent providers, in small numbers and close 
geographic proximity. Lower care fragmentation, coupled with enhanced medical education 
and technical infrastructure might beneﬁt patients, by savings on travel times and costs, and 
the wider society, by savings on pharmacy costs. It appears beneficial to develop incentive 
schemes with the objective of encouraging general practitioners to enhance strong 
relationship with their specialist counterparts.  
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